The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

Hims stock popped Monday after the FDA reportedly said it would reconsider its decision to bar compounders from selling knockoff tirzepatide.

The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling medicines while it reevaluates its recent decision to declare the drugs back in ...

Best Stocks to Invest in Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands ...

With so many treatments and drugs accessible, compounded semaglutide has recently garnered a lot of favor. Semaglutide, which ...

One notable standout from Mayer’s list of diet myths is the section on diet pills and ... With the advent of Ozempic and related obesity drugs, some might say the search is finally over. These ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

While supply chain diversification and the US Biosecure Act can help Divi's target the $800 million revenue opportunity from ...

However, the stock market largely attributes value to a company based on its ability to generate earnings in the future. Based on Lilly’s next twelve months forward P/E ratio, investors are paying ...

Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

A health care spending surge looms in the new year, and Business Group on Health is helping employers understand it. The ...

As for why it’s not approved for weight loss in the UK, Dr Kayat added: “It works by helping to regulate your appetite and ...